As of May 31, 2025, FSD Pharma Inc (HUGE.CN) reports a Gross Margin of -647.08%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of FSD Pharma Inc's Gross Margin
Over recent years, FSD Pharma Inc's Gross Margin has shown limited historical data. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2021-12-31 | -647.08% |
| 2020-12-31 | -643.56% |
This trend highlights how FSD Pharma Inc manages its operational efficiency and pricing power over time.
Comparing FSD Pharma Inc's Gross Margin to Peers
To better understand FSD Pharma Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| FSD Pharma Inc (HUGE.CN) | -647.08% |
| Tetra Bio Pharma Inc (TBP.TO) | 7775.20% |
| Avenue Therapeutics Inc (ATXI) | 7775.20% |
| American Green Inc (ERBB) | 7775.20% |
| PainReform Ltd (PRFX) | 7775.20% |
| MJ Holdings Inc (MJNE) | 100.00% |
Compared to its competitors, FSD Pharma Inc's Gross Margin is lower than all peers, suggesting potential challenges in production costs or pricing strategy.